Dry Eye Response to Interval Exercise and Mediterranean Diet

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05248698
Collaborator
(none)
60
1
2
11.8
5.1

Study Details

Study Description

Brief Summary

in the recent times, dry eye was found to be correlated sedentary life style, obesity, hypertension. So, changing the sedentary lifestyle is recommended

Condition or Disease Intervention/Treatment Phase
  • Behavioral: lifestyle change
  • Other: exercise
N/A

Detailed Description

older patient who will complain from dry eye will be collected. it is planned to recruit 60 elderly (with obesity and hypertension) to be distributed into group 1 (this group will receive 3-time interval exercise per the week, applied for 30 min with high intensity, plus Mediterranean Diet) and group 2 (this group will receive only 3-time interval exercise per the week, applied for 30 min with high intensity). Every group will contain 30 elderly

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Dry Eye Response to Interval Exercise (High Intensity Aerobic Activity) and Mediterranean Diet
Actual Study Start Date :
Jan 5, 2022
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: group 1

30 older patient who will complain from dry eye will receive 3-time interval exercise per the week, applied for 30 min with high intensity, plus Mediterranean Diet for 6 months

Behavioral: lifestyle change
30 older patient who will complain from dry eye will receive 3-time interval exercise per the week, applied for 30 min with high intensity, plus Mediterranean Diet for 6 months

Active Comparator: group 2

30 older patient who will complain from dry eye will receive 3-time interval exercise per the week, applied for 30 min with high intensity, for 6 months

Other: exercise
30 older patient who will complain from dry eye will receive 3-time interval exercise per the week, applied for 30 min with high intensity, for 6 months

Outcome Measures

Primary Outcome Measures

  1. Schirmer's test [6 months]

    tear-production speed test

Secondary Outcome Measures

  1. scoring system for dry eye [6 months]

    it is a questionnaire will assess dry-eye severity

  2. Ocular surface disability index [6 months]

    it is a questionnaire will assess complaints of patients due to severity of dry-eye

  3. tear film break up time testing [6 months]

    it is a test that will assess tear film stabilization

  4. Oxford grading system [6 months]

    a test will examine ocular epithelial damage

  5. blood systole [6 months]

    it will be measured by sphygmomanometer

  6. blood diastole [6 months]

    it will be measured by sphygmomanometer

  7. weight [6 months]

    it will be expressed in kilograms

  8. body mass index [6 months]

    it will be gained by dividing weight of subject on his or her squared height

  9. waist circumference [6 months]

    it will be evaluated by tape measurements of treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • elderly patients with dry eye complaints

  • the patients will be obese and hypertensives

Exclusion Criteria:
  • heart or respiration problems

  • other diagnosed eye or systemic diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairo Unoversity Giza Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Ali Ismail, lecturer, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ali Mohamed Ali ismail, principal investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT05248698
Other Study ID Numbers:
  • P.T.REC/012/003553
First Posted:
Feb 21, 2022
Last Update Posted:
Feb 21, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2022